scispace - formally typeset
Open AccessJournal Article

Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

M E Kaighn, +4 more
- 01 Jul 1979 - 
- Vol. 17, Iss: 1, pp 16-23
TLDR
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.
Abstract
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents

read more

Citations
More filters
Journal ArticleDOI

Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans

TL;DR: The finding that carbogen gas breathing improves prostate tumour oxygenation provides a rationale for testing the radiosensitising effects of combining carbogenGas breathing with radiotherapy in prostate cancer patients.
Journal ArticleDOI

Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter.

TL;DR: The results suggested that the FABP5-PPARγ-VEGF signal transduction axis, rather than androgen modulated route, may be a more important novel therapeutic target for angiogenesis-suppression treatment of castration resistant prostate cancer.
Journal ArticleDOI

Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines

TL;DR: Investigation of the expression of MMPs and endogenous inhibitors in two parent epithelial prostate cancer cell lines and sublines of increasing invasive/metastatic potential found MMP-1, M MP-13 and TIMP-1 was higher in the more aggressive sublines and may be implicated in invasive/ metastatic ability.
Journal ArticleDOI

A novel coculture model for benign prostatic hyperplasia expressing both isoforms of 5 alpha-reductase

TL;DR: A cocultures of fibroblasts and epithelial cells derived from benign prostatic hyperplasia maintained messenger ribonucleic acid expression and functional activity for both isoenzymes of 5α-reductase (type I and type II) and maintained expression of androgen receptors and prostate-specific antigen.
Journal ArticleDOI

U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia

TL;DR: A murine U19/Eaf2 knockout mouse model provides a unique animal model for three important cancers: lung adenocarcinoma, B-cell lymphoma and hepatocellular carcinoma and the knockout mice also exhibited cardiac cell hypertrophy, indicating a role for U18/EAF2 in growth suppression and cell size control as well as arguing for U19-Eaf 2 as a novel tumor suppressor in multiple mouse tissues.
Related Papers (5)